Research Article | Open Access
Elena B. Menshchikova, Peter M. Kozhin, Anton V. Chechushkov, Marina V. Khrapova, Nikolay K. Zenkov, "The Oral Delivery of Water-Soluble Phenol TS-13 Ameliorates Granuloma Formation in an In Vivo Model of Tuberculous Granulomatous Inflammation", Oxidative Medicine and Cellular Longevity, vol. 2021, Article ID 6652775, 10 pages, 2021. https://doi.org/10.1155/2021/6652775
The Oral Delivery of Water-Soluble Phenol TS-13 Ameliorates Granuloma Formation in an In Vivo Model of Tuberculous Granulomatous Inflammation
The redox-sensitive signaling system Keap1/Nrf2/ARE is a premier protective mechanism against oxidative stress that plays a key role in the pathogenesis and development of various diseases, including tuberculous granulomatous inflammation. We have previously reported that novel water-soluble phenolic antioxidant TS-13 (sodium 3-(4-methoxyphenyl)propyl thiosulfonate) induces Keap1/Nrf2/ARE and attenuates inflammation. The aim of this study is the examination of the effect of TS-13 on tuberculous granulomatous inflammation. BALB/c mice were administered TS-13 (100 mg kg-1 day-1) through their drinking water starting immediately after Bacillus Calmette-Guérin (BCG) intravenous injection. Histological changes, production of reactive oxygen species (ROS) (activity of free-radical oxidation processes), and mRNA expression of Nrf2-driven, NF-κB-, AP-1-, and autophagy-dependent signal pathway genes in the liver and peritoneal exudate were evaluated 30 days later. After the 30th day of infection, the activity of the Keap1/Nrf2/ARE system was decreased and its effector genes entailed increasing ROS production in the liver. Therapeutic intervention with TS-13 is aimed at activating the Keap1/Nrf2/ARE system that leads to an increase in Nrf2 and Nrf2-mediated gene expression and a decrease in NF-κB expression. Changes in these pathways resulted in a decline of ROS production and a decrease in the number and the size of granulomas. In total, the results indicate that the Keap1/Nrf2/ARE system can be an effective pharmacological target in host-adjunctive treatment of tuberculosis.
Before the advent of specific antituberculosis drugs (streptomycin, isoniazid, ethambutol, rifampicin, and pyrazinamide) in the middle of the last century, pathogenetic therapy was aimed at reestablishing an ablated immune system and correcting disturbed vital processes; this was the main treatment for patients with tuberculosis. The antimycobacterial therapy demonstrated undoubted success, and resorting to treatment using a specific diet (fish oil or cod liver oil rich in vitamin D) and other methods of pathogenetic therapy have fallen into oblivion or have been put aside. The development of combinatorial therapeutic modalities with the involvement of additional antimycobacterial agents and conventional chemotherapy indicated a breakthrough in therapeutic interventions for tuberculosis, especially in cases of multidrug-resistant tuberculosis. Among the recent drug discoveries, new “host-targeted” adjunct therapeutic strategies have emerged [1–5].
Without a doubt, the additional use of pathogenetic therapy significantly influences tuberculosis treatment and results in better recovery of the functional state in vital systems of the body. In particular, it is the strategy affecting specific signaling systems and key transcription factors, especially redox-dependent (nuclear factor κB (NF-κB) [6–8], activating protein-1 (AP-1) , NFE2-related factor 2 (Nrf2)) [8–10] and other key cell processes, including autophagy [4, 6, 11] and lysosomal biogenesis .
The key point in Mycobacterium tuberculosis survival and persistence in the host is its uptake by macrophages and the subsequent formation of granulomas. The factors involved in the formation and sustainment of tuberculous granuloma are not well understood, but they involve adaptations of both the host and pathogen to a changing microenvironment and redox state. Whether granuloma plays a protective or destructive role in tuberculosis pathogenesis and treatment is the subject of great debates [1, 4, 12]. Besides, the precise mechanisms underlying the redox biology of granulomatous tuberculous inflammation are still obscure. Therefore, the master regulator signaling system Keap1/Nrf2/ARE (Kelch-like ECH-associated protein 1/NFE2-related factor 2/antioxidant respons(iv)e element) can serve as an important target in the pathogenetic treatment of tuberculosis affecting antioxidant protection, xenobiotic detoxification, and activity of reactive oxygen species- (ROS-) generating enzymes [10, 13–15].
In this connection, we have been investigating the impact of sulfur-containing phenolic antioxidant TS-13 on the activation Nrf2 transcription factor , on Bacillus Calmette-Guérin- (BCG-) induced granuloma formation and ROS production in mice.
2. Materials and Methods
Luminol was purchased from SERVA Electrophoresis GmbH; 2,7-dichlorodihydrofluorescein diacetate and TRIzol Reagent were obtained from Invitrogen; phorbol 12-myristate 13-acetate (PMA) and zymosan were obtained from Sigma-Aldrich; anti-Nrf2 antibodies (ab31163) were purchased from Abcam; RNAlater was purchased from Qiagen; iScript cDNA Synthesis Kit was obtained from Bio-Rad; BioMaster HS-qPCR mix was obtained from Biolabmix; culture media and fetal bovine serum were purchased from Biolot Medical; mounting media were obtained from BioVitrum; BCG vaccine was obtained from Microgen; and sodium 3-(4-methoxyphenyl)propyl thiosulfonate (TS-13, Figure 1) was synthesized based on 2,6-di-tert-butyl-phenоl as described previously . The main substance content in the sample measured by HPLC was 98–99.2%. All other chemicals were analytical grade and were obtained from standard commercial supplies.
2.2. Animal Model
The experimental protocol was approved by the Animal Care Committee of the Federal Research Center for Fundamental and Translational Medicine (Novosibirsk, Russia). Male BALB/c mice (weight: 18–22 g; age: 2 months) were purchased from the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences (Novosibirsk, Russia). The animals were housed in an environment where temperature and light were controlled, and food and water were provided ad libitum. Mice were injected with 0.5 mg BCG in 0.2 mL saline solution into the tail vein (two groups, 8 animals per group) or 0.2 mL saline solution as a vehicle control (control group, ). One group of BCG-infected animals was supplemented with a daily dose of 100 mg kg-1 day-1 TS-13 dissolved in drinking water for 30 days, while the other groups received water. Mice were sacrificed by cervical dislocation. Peritoneal macrophages were isolated to evaluate the oxidative metabolism of these cells. The livers were quickly removed, weighed, and processed for histological and immunohistochemical examination and preparation of liver homogenates. Samples were collected and stored in RNAlater with subsequent nucleic acid extraction.
2.3. Histological Examination
Liver fragments were fixed in 10% neutral formalin, dehydrated in ascending alcohol solutions, and embedded in paraffin. Sections (4-5 μm thick) were stained using the hematoxylin/eosin techniques and studied using light microscopy (AxioImager A1, Carl Zeiss). Specific histochemical staining by the Ziehl-Neelsen stain was used to visualize Mycobacterium bovis in the tissues. The numerical density of the granulomas and their diameters were determined by using the morphometry method (AxioVision software, rel. 4.8). These parameters were used as the morphological criteria for tuberculosis activity.
For immunohistochemical study, 3 μm sections were dewaxed and dehydrated, and epitopes were retrieved in citrate buffer solution in a 700 W microwave oven for 20-35 minutes. Endogenous peroxidase was blocked. The samples were incubated with primary anti-Nrf2 antibodies according to instructions. Then, the sections were incubated with horseradish peroxidase (HRP) conjugate (using a Spring Bioscience Corporation detection system) and 3,3-diaminobenzidine (DAB) substrate and then stained with Mayaer’s hematoxylin. Sections were dehydrated using increasing concentrations of ethanol and xylol mounted with synthetic mounting media “Bio Mount,” placed under cover glasses and studied using light microscopy (AxioImager A1, Carl Zeiss).
2.4. Activity of Free-Radical Oxidation Processes
2.4.1. Chemiluminescence (CL)
The livers were rinsed with saline, minced with scissors, and homogenized on ice in a Potter-Elvehjem tissue grinder with 5 vol (/) of Hanks’ balanced salt solution without phenol red (HBSS) (200 mg/mL). After recording the background CL of the measuring cuvette at 37°C in a chemiluminometer (Photon, Russia) for 2 minutes, 2 mL of liver homogenate was placed in the cuvette and then incubated for 2 minutes; then, the spontaneous CL was measured for 2 minutes. Afterwards, 0.1 mL of 100 nM luminol solution was injected, and the luminol-amplified CL (LACL) was measured for 2 minutes. Then, 0.1 mL of H2O2 solution was added (final concentration 39.5 mM), and the H2O2-induced luminol-amplified CL (H2O2-LACL) was measured. The results were normalized to the CL intensity in control mice.
2.4.2. Flow Cytometry
Peritoneal exudate cells (PECs) were obtained by peritoneal lavage with cold RPMI 1640 medium supplemented with 1% (/) fetal bovine serum and kept on ice until measured. To measure the total ROS production, isolated PECs were incubated for 15 min in 1 mL of HBSS containing 10 μM 2,7-dichlorodihydrofluorescein (DCF) diacetate at +37°C. The former is deacylated intracellularly and rapidly oxidized by ROS (predominantly H2O2) to yield the highly fluorescent product DCF. We measured the intensity of the DCF-dependent fluorescence of PECs stimulated with 100 nM PMA (, ) by using the FACSCalibur (Becton Dickinson, USA) flow cytometer. The gating of the viable macrophages and neutrophils was based on light scattering (forward and side scatter) properties. The results of the cell fluorescence intensity were normalized to the fluorescence in control mice.
2.5. Quantitative Real-Time PCR
Total RNA was extracted from tissue using the TRIzol Reagent. Total RNA was converted to cDNA using the iScript cDNA Synthesis Kit. The real-time PCR reactions were carried out using a BioMaster HS-qPCR mix. All reactions were run in triplicate in 96-well plates on a CFX96 system (Bio-Rad), and threshold cycles (Cts) were obtained after 40 cycles. A quantitative assessment was carried out by the delta delta Ct method, and the glyceraldehyde 3-phosphate dehydrogenase (Gapdh) gene was used as a reference gene. Primers used in real-time PCR are listed in Table 1.
2.6. Statistical Analysis
The Kolmogorov-Smirnov test was used to check whether the variables were normally distributed. For variables with a normal distribution, the one-way ANOVA with post hoc Tukey’s test was used for multiple comparisons, and the data are represented as the . Nonnormally distributed variables were evaluated using the Kruskal-Wallis with post hoc Dunn’s test. In case of not normally distributed data the Kruskal-Wallis with post hoc Dunn’s test was applied. The data were represented as the median and the lower (Q1) and upper (Q3) quartiles. The relationships between the variables were assessed by Spearman’s rank correlation coefficient (). Differences between experimental groups and correlations were considered as statistically significant at a value of less than 0.05.
3. Results and Discussion
3.1. TS-13 Inhibits Granuloma Formation and Enhances Nrf2 Expression (Histological Examinations)
Histological examination showed that disseminated tuberculous inflammation developed 30 days after infection in mice. It was manifested morphologically as BCG granuloma formation in the liver. M. bovis bacteria were detected in the foci of the granulomatous inflammation. Granuloma formations around infected macrophages are the hallmarks of chronic mycobacterial infection. The numerical density and diameter of granulomas serve as morphological criteria for the therapeutic efficiency of antituberculosis drugs.
BCG injection induced a marked granulomatous response in the liver of mice with the formation of diffuse, principally perivascular granulomas consisting primarily of macrophages and containing a considerable content of lymphocytes. Morphometric analysis showed that 30 days of TS-13 treatment was followed by a significant 2.5- and 1.4-time decrease in granuloma numerical density and diameter, respectively (Figure 2(a)). Besides, granulomas in the liver of BCG-injected TS-13-treated mice contained significantly less epithelioid cells (by 29.8%) and neutrophils (complete absence) in comparison with BCG-injected TS-13-untreated animals (Figure 2(b)).
Immunohistochemical analysis of liver samples has demonstrated weak Nrf2 expression with cytoplasmic localization in the control group. In the BCG-infected group, Nrf2 expression was more pronounced in hepatocytes with minimal expression in granulomas. In BCG-infected TS-13-treated mice, Nrf2 was abundant with cytoplasmic and nuclear localization and strong expression in granulomas (Figure 3).
3.2. Bidirectional Effect of TS-13 on Free-Radical Oxidation Processes
Spontaneous CL is a measure of the generation of lipid alkoxyl and peroxyl radicals, i.e., the intensity of lipid peroxidation [17, 18]. Spontaneous CL levels of liver homogenates did not differ significantly among groups, but when luminol was introduced into a registration system, we observed a significant increase of CL intensity in the BCG-infected group; the same was observed after adding H2O2 (Figure 4(a)). The levels of liver LACL and H2O2-LACL intensity of the BCG-infected mice receiving TS-13 were significantly lower in comparison with those of the positive control (BCG-injected mice that received water) (Figure 4(a)).
The PMA-stimulated ROS production by PECs in total and by peritoneal neutrophils from BCG-infected mice was similar to the negative control, whereas DCF-dependent fluorescence of peritoneal macrophages was significantly lower (Figure 4(b)). In BCG-infected TS-13-treated mice, PMA-stimulated fluorescence of total PECs, peritoneal macrophages, and peritoneal neutrophils was statistically higher compared to the corresponding positive control group (Figure 4(b)).
3.3. Enhancement of ARE-Driven Pathway by TS-13 Treatment and Effect on NF-κB-, AP-1-, and Autophagy-Dependent Signal Pathways (Gene Expression Analysis)
First, we assessed the effect of TS-13 on the expression of genes involved in redox-dependent signaling pathways, namely, Nrf2-, NF-κB-, and AP-1-mediated (Figure 5). 30 days after BCG infection, mRNA expression of Nrf2 significantly decreased and mRNA content of ARE-driven enzymes (NQO1, glutathione S-transferase P1, and heme oxygenase 1) tended to decrease in the liver of BCG-infected mice in comparison with negative control. An evaluation of mRNA expression of those genes in BCG-infected animals receiving TS-13 with drinking water revealed higher levels of Nfe2l2, Nqo1, Gstp1, and Hmox1 mRNAs relative to positive control (BCG-infected mice). The expression pattern of p65 (Rela), an important subunit of the classical NF-κB pathway, was similar in all 3 groups with a tendency of increasing () in the third group compared to negative control, whereas p100 (Nfkb2) mRNA content increased in the BCG-infected group compared to negative control, indicating the alternative activation of NF-κB, which tended to decrease in BCG-infected TS-13-treated mice. Expression of the c-Jun protooncogene (AP-1, Jun) was upregulated in the BCG-infected group with a significant decrease in the TS-13-treated group.
Expression of autophagy effector gene Map1lc3b (Figure 6(a)) after 30 days of infection did not change in both groups.Becn1 mRNA expression tended to be more pronounced in the BCG+TS-13 group as compared to positive control () (Figure 6(b)). Expression of lysosomal biogenesis genes Tfeb (Figure 6(c)) and Tfe3 (Figure 6(d)) tended to increase in the BCG group (Tfeb mRNA content enhanced significantly). However, Tfeb expression decreased to control value in the liver of TS-13-treated mice.
The main purpose of our study is to establish ROS production during experimental tuberculosis in mice and to determine whether induction of the Keap1/Nrf2/ARE signaling pathway could affect granuloma formation.
The lack of Nrf2 nuclear translocation in the BCG-infected group would suggest a defect in Nrf2-mediated antioxidant defense, as previously described [10, 19]. This fact was confirmed by evaluating the expression of the following Nrf2-mediated genes: Nqo1, Gstp1, and Hmox1. Decreased activity of the Keap1/Nrf2/ARE system and its effector genes entails increasing ROS production in the liver. Therapeutic intervention with TS-13 is aimed at activating the Keap1/Nrf2/ARE system that leads to an increase in Nrf2 and Nrf2-mediated gene expression and a decrease in NF-κB expression. The changes in these pathways resulted in a reduction of ROS generation and a decrease in the number and size of granulomas.
We examined the association between the severity of granuloma formation, the intensity of free-radical oxidation processes, and the expression of the Keap1/Nrf2/ARE signaling pathway genes (Table 2). A multivariate regression analysis showed that the free-radical processes involving ROS were important for BCG-induced formation of granulomas in the liver. This is confirmed by our previous assumption of the steady-state hydrogen peroxide concentration increasing in granulomas .
: numerical density of granulomas; : diameter of granulomas; CL: chemiluminescence; LACL: luminol-amplified chemiluminescence; H2O2-LACL: H2O2-induced luminol-amplified chemiluminescence; PECS: DCF-dependent fluorescence of PMA-stimulated peritoneal exudate cells; Nfe2l2, NQO1, Gstp1, and Hmox1: mRNA expression of appropriate genes. Significant values.
Contribution of classical pathway activation of the proinflammatory transcription factor NF-κB was limited. Furthermore, there was an inverse relationship between Rela expression and ROS generation and a direct dependence between Rela and Nfe2l2 expression. In contrast, the infection process was accompanied by alternative NF-κB pathway activation that correlated with the H2O2 production and the c-Jun subunit of transcription factor AP-1 expression.
After 30 days of infection, there was an inverse relationship between the severity of granulomas or ROS formation and Becn1 expression. This phenomenon is consistent with observations that tuberculous granulomatous inflammation is accompanied by autophagy inhibition, including a decline of Becn1 expression [5, 10, 11, 21]. At the same time, the elevated levels of expression of lysosomal biogenesis genes Tfe3 and Tfeb positively correlated with expression of Nfkb2 and Jun genes, characterizing the alternative macrophage activation status. The TFEB transcription factor ortholog is a key regulator of immune responses in Candida elegans, coordinating expression of genes that are controlled by NF-κB (absent in C. elegans) in mammals. Probably, TFEB is one of the oldest high-level regulators of nonspecific immune resistance, which lost the leading role in immune reactions in mammals in connection with the appearance of the more universal regulator NF-κB.
Increased PMA-stimulated ROS production by peritoneal macrophages in BCG-infected TS-13-treated animals might be due to the enhancement of Nox4 expression as a result of Nrf2 activation under the influence of TS-13 [22, 23]. Mice with partial Keap1 knockout (constitutive activation of Nrf2) is known to have an increased expression of NADPH oxidase homolog NOX4 . PMA stimulation leads to the activation of the NOX4 enzyme and ROS production [23, 24]. At the same time, Nrf2 contributed to the regulation of purine biosynthesis by controlling the expression of genes encoding enzymes in the pentose phosphate pathway, and induction of the Keap1/Nrf2/ARE system might be followed by an increase in the generation of NADPH that is essential for NADPH oxidase-dependent ROS production during a phagocyte respiratory burst [25–27].
It was shown that the induction of the redox-sensitive signaling system Keap1/Nrf2/ARE in a tuberculous inflammation model reduces the number and size of granulomas and changes the cellular composition of granulomas by decreasing the content of neutrophils (the main destructive factor of inflammation) and epithelioid cells (a factor of the maturity of granulomas). Our results suggest that the Keap1/Nrf2/ARE system could be a plausible and promising pharmacological target for tuberculosis treatment.
The data obtained in this study are available from the corresponding author upon request.
Conflicts of Interest
The authors have no conflicts of interest to declare.
This research was supported by the Fundamental Scientific Research Programs for 2020–2022 “Redox regulation of cell functional activity and its role in the development of malignant neoplasms” and involved the use of equipment from the Multiaccess Center “Modern Optical Systems” of the Federal Research Center of Fundamental and Translational Medicine (Novosibirsk, Russia).
- D. Kiran, B. K. Podell, M. Chambers, and R. J. Basaraba, “Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review,” Seminars in Immunopathology, vol. 38, no. 2, pp. 167–183, 2016.
- A. Mourenza, J. A. Gil, L. M. Mateos, and M. Letek, “Novel treatments against Mycobacterium tuberculosis based on drug repurposing,” Antibiotics (Basel), vol. 9, no. 9, p. 550, 2020.
- P. Desikan and A. Rangnekar, “Host-targeted therapy for tuberculosis: time to revisit the concept,” The Indian Journal of Medical Research, vol. 147, no. 3, pp. 233–238, 2018.
- D. Ashley, J. Hernandez, R. Cao et al., “Antimycobacterial effects of everolimus in a human granuloma model,” Journal of Clinical Medicine, vol. 9, no. 7, p. 2043, 2020.
- S. Ahmed, R. Raqib, G. H. Guethmundsson, P. Bergman, B. Agerberth, and R. S. Rekha, “Host-directed therapy as a novel treatment strategy to overcome tuberculosis: targeting immune modulation,” Antibiotics (Basel), vol. 9, no. 1, p. 21, 2020.
- H. J. Lee, H. J. Ko, S. H. Kim, and Y. J. Jung, “Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages,” PLoS One, vol. 14, no. 3, article e0199799, 2019.
- H. S. Lee, H. S. Hua, C. H. Wang, M. C. Yu, B. C. Chen, and C. H. Lin, “Mycobacterium tuberculosis induces connective tissue growth factor expression through the TLR2-JNK-AP-1 pathway in human lung fibroblasts,” The FASEB Journal, vol. 33, no. 11, pp. 12554–12564, 2019.
- A. Ruiz, C. Sarabia, M. Torres, and E. Juarez, “Resolvin D1 (RvD1) and maresin 1 (Mar1) contribute to human macrophage control of M. tuberculosis infection while resolving inflammation,” International Immunopharmacology, vol. 74, p. 105694, 2019.
- Q. Sun, X. Shen, J. Ma, H. Lou, and Q. Zhang, “Activation of Nrf2 signaling by oltipraz inhibits death of human macrophages with Mycobacterium tuberculosis infection,” Biochemical and Biophysical Research Communications, vol. 531, no. 3, pp. 312–319, 2020.
- Z. Qian, J. Lv, G. T. Kelly et al., “Expression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis,” Tuberculosis (Edinburgh, Scotland), vol. 99, pp. 56–62, 2016.
- S. Pahari, S. Negi, M. Aqdas, E. Arnett, L. S. Schlesinger, and J. N. Agrewala, “Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of Mycobacterium tuberculosis,” Autophagy, vol. 16, no. 6, pp. 1021–1043, 2020.
- M. Catala, C. Prats, D. Lopez, P. J. Cardona, and S. Alonso, “A reaction-diffusion model to understand granulomas formation inside secondary lobule during tuberculosis infection,” PLoS One, vol. 15, no. 9, article e0239289, 2020.
- N. K. Zenkov, P. M. Kozhin, A. V. Chechushkov, G. G. Martinovich, N. V. Kandalintseva, and E. B. Menshchikova, “Mazes of Nrf2 regulation,” Biochemistry (Moscow), vol. 82, no. 5, pp. 556–564, 2017.
- A. Cuadrado, A. I. Rojo, G. Wells et al., “Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases,” Nature Reviews. Drug Discovery, vol. 18, no. 4, pp. 295–317, 2019.
- S. Kovac, P. R. Angelova, K. M. Holmström, Y. Zhang, A. T. Dinkova-Kostova, and A. Y. Abramov, “Nrf2 regulates ROS production by mitochondria and NADPH oxidase,” Biochimica et Biophysica Acta, vol. 1850, no. 4, pp. 794–801, 2015.
- E. Menshchikova, V. Tkachev, A. Lemza et al., “Water-soluble phenol TS-13 combats acute but not chronic inflammation,” Inflammation Research, vol. 63, no. 9, pp. 729–740, 2014.
- Y. A. Vladimirov and E. V. Proskurnina, “Free radicals and cell chemiluminescence,” Biochemistry (Mosc), vol. 74, no. 13, pp. 1545–1566, 2009.
- Z. N. Özdemir-Kumral, B. E. Erkek, B. Karakuş et al., “Potential Effect of 1,25 Dihydroxyvitamin D3 on Thioacetamide-Induced Hepatotoxicity in Rats,” The Journal of Surgical Research, vol. 243, pp. 165–172, 2019.
- G. S. Palanisamy, N. M. Kirk, D. F. Ackart, C. A. Shanley, I. M. Orme, and R. J. Basaraba, “Evidence for oxidative stress and defective antioxidant response in guinea pigs with tuberculosis,” PLoS One, vol. 6, no. 10, article e26254, 2011.
- E. Menshchikova, N. Zenkov, V. Tkachev, O. Potapova, L. Cherdantseva, and V. Shkurupiy, “Oxidative stress and free-radical oxidation in BCG granulomatosis development,” Oxidative Medicine and Cellular Longevity, vol. 2013, 452548 pages, 2013.
- W. Ornatowski, Q. Lu, M. Yegambaram et al., “Complex interplay between autophagy and oxidative stress in the development of pulmonary disease,” Redox Biology, vol. 36, p. 101679, 2020.
- S. Pendyala, J. Moitra, S. Kalari et al., “Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the Nox4 promoter,” Free Radical Biology & Medicine, vol. 50, no. 12, pp. 1749–1759, 2011.
- D. Chai, L. Zhang, S. Xi, Y. Cheng, H. Jiang, and R. Hu, “Nrf2 activation induced by Sirt1 ameliorates acute lung injury after intestinal ischemia/reperfusion through NOX4-mediated gene regulation,” Cellular Physiology and Biochemistry, vol. 46, no. 2, pp. 781–792, 2018.
- M. Breitenbach, M. Rinnerthaler, M. Weber et al., “The defense and signaling role of NADPH oxidases in eukaryotic cells : review,” Wiener Medizinische Wochenschrift (1946), vol. 168, no. 11-12, pp. 286–299, 2018.
- J. Baardman, S. G. S. Verberk, K. H. M. Prange et al., “A defective pentose phosphate pathway reduces inflammatory macrophage responses during hypercholesterolemia,” Cell Reports, vol. 25, no. 8, pp. 2044–2052.e5, 2018, e5.
- X. Zhang, H. Dong, F. Wang, and J. Zhang, “Mast cell deficiency protects mice from surgery-induced neuroinflammation,” Oxidative Medicine and Cellular Longevity, vol. 2020, Article ID 1921826, 7 pages, 2020.
- J. D. Hayes and A. T. Dinkova-Kostova, “The Nrf2 regulatory network provides an interface between redox and intermediary metabolism,” Trends in Biochemical Sciences, vol. 39, no. 4, pp. 199–218, 2014.
Copyright © 2021 Elena B. Menshchikova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.